Myopia Pathways May Guide Control
Review links environmental, optical, and genetic drivers to strategies that may slow eye growth
By
Andrea Surnit
April 13, 2026
Clinical Scorecard: Myopia Pathways May Guide Control
At a Glance
Category Detail
Condition Myopia Key Mechanisms Disrupted vision-guided eye growth influenced by environmental exposure and genetic susceptibility. Target Population Patients aged 6 to 14 years, particularly those with higher accommodative lag and increased near work exposure. Care Setting Clinical settings, including optometry and ophthalmology practices.
Key Highlights
Environmental exposures induce optical defocus affecting eye growth. Increased outdoor exposure linked to reduced myopia incidence. Orthokeratology and multifocal lenses significantly reduce axial elongation. Low-dose atropine shows substantial reduction in myopia progression. Genetic factors interact with environmental exposure to influence progression. Guideline-Based Recommendations
Diagnosis
Assess visual acuity and refractive error in children. Monitor axial length as a measure of myopia progression. Management
Implement optical control strategies such as orthokeratology and multifocal lenses. Consider low-dose atropine for myopia management. Monitoring & Follow-up
Regular follow-up to assess changes in refractive error and axial length. Evaluate the impact of increased outdoor activity on myopia progression. Risks
Potential for increased myopia progression with excessive near work. Variability in treatment response based on genetic factors. Patient & Prescribing Data
Children aged 6 to 14 years at risk of myopia progression.
Tailored interventions based on individual risk factors and progression stage are essential.
Clinical Best Practices
Encourage increased outdoor activity to mitigate myopia risk. Utilize a combination of optical interventions for optimal control. Standardize longitudinal research to clarify conflicting findings. Related Resources & Content
